Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities. (7th January 2022)
- Record Type:
- Journal Article
- Title:
- Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities. (7th January 2022)
- Main Title:
- Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities
- Authors:
- Fojo, Anthony
Wallengren, Emma
Schnure, Melissa
Dowdy, David W
Shah, Maunank
Kasaie, Parastu - Abstract:
- Abstract: Background: The degree to which the 2019 novel coronavirus disease (COVID-19) pandemic will affect the US human immunodeficiency virus (HIV) epidemic is unclear. Methods: We used the Johns Hopkins Epidemiologic and Economic Model to project HIV infections from 2020 to 2025 in 32 US metropolitan statistical areas (MSAs). We sampled a range of effects of the pandemic on sexual transmission (0–50% reduction), viral suppression among people with HIV (0–40% reduction), HIV testing (0–50% reduction), and pre-exposure prophylaxis use (0–30% reduction), and indexed reductions over time to Google Community Mobility Reports. Results: Simulations projected reported diagnoses would drop in 2020 and rebound in 2021 or 2022, regardless of underlying incidence. If sexual transmission normalized by July 2021 and HIV care normalized by January 2022, we projected 1161 (1%) more infections from 2020 to 2025 across all 32 cities than if COVID-19 had not occurred. Among "optimistic" simulations in which sexual transmission was sharply reduced and viral suppression was maintained we projected 8% lower incidence (95% credible interval: 14% lower to no change). Among "pessimistic" simulations where sexual transmission was largely unchanged but viral suppression fell, we projected 11% higher incidence (1–21% higher). MSA-specific projections are available at www.jheem.org?covid . Conclusions: The effects of COVID-19 on HIV transmission remain uncertain and differ between cities. ReportedAbstract: Background: The degree to which the 2019 novel coronavirus disease (COVID-19) pandemic will affect the US human immunodeficiency virus (HIV) epidemic is unclear. Methods: We used the Johns Hopkins Epidemiologic and Economic Model to project HIV infections from 2020 to 2025 in 32 US metropolitan statistical areas (MSAs). We sampled a range of effects of the pandemic on sexual transmission (0–50% reduction), viral suppression among people with HIV (0–40% reduction), HIV testing (0–50% reduction), and pre-exposure prophylaxis use (0–30% reduction), and indexed reductions over time to Google Community Mobility Reports. Results: Simulations projected reported diagnoses would drop in 2020 and rebound in 2021 or 2022, regardless of underlying incidence. If sexual transmission normalized by July 2021 and HIV care normalized by January 2022, we projected 1161 (1%) more infections from 2020 to 2025 across all 32 cities than if COVID-19 had not occurred. Among "optimistic" simulations in which sexual transmission was sharply reduced and viral suppression was maintained we projected 8% lower incidence (95% credible interval: 14% lower to no change). Among "pessimistic" simulations where sexual transmission was largely unchanged but viral suppression fell, we projected 11% higher incidence (1–21% higher). MSA-specific projections are available at www.jheem.org?covid . Conclusions: The effects of COVID-19 on HIV transmission remain uncertain and differ between cities. Reported diagnoses of HIV in 2020–2021 are likely to correlate poorly with underlying incidence. Minimizing disruptions to HIV care is critical to mitigating negative effects of the COVID-19 pandemic on HIV transmission. Abstract : The impact of the COVID-19 pandemic on HIV is uncertain and depends on its local effects on sexual transmission and viral suppression. Reported cases of HIV during and following the pandemic will likely not correlate well with underlying incidence. … (more)
- Is Part Of:
- Clinical infectious diseases. Volume 75:Number 1(2022)
- Journal:
- Clinical infectious diseases
- Issue:
- Volume 75:Number 1(2022)
- Issue Display:
- Volume 75, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 75
- Issue:
- 1
- Issue Sort Value:
- 2022-0075-0001-0000
- Page Start:
- e1145
- Page End:
- e1153
- Publication Date:
- 2022-01-07
- Subjects:
- HIV -- COVID-19 -- dynamic HIV transmission model -- infectious disease transmission
Communicable diseases -- Periodicals
616.905 - Journal URLs:
- http://cid.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.journals.uchicago.edu/CID/journal ↗
http://www.jstor.org/journals/10584838.html ↗ - DOI:
- 10.1093/cid/ciab1029 ↗
- Languages:
- English
- ISSNs:
- 1058-4838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.293860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23126.xml